AnalystsJames CondulisJames Condulis's Stock Forecasts
AnalystsJames Condulis
Sectors:
Industries:
Analyst Ranking
Bottom 19%
#4219 out of 5206 analysts
Average Return
-3.6%
Win Rate
38%3 out of 8
Risk vs Reward
Poor
Good
James Condulis's 5 best and worst ratings
James Condulis Analyst Color
Get additional color on James Condulis's coverage of popular stocks
James Condulis's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Aardvark Therapeutics IncAARD | 2 | Hold | $6.00 | +9.69% | Downgrades | a day ago |
Newamsterdam Pharma Co NvNAMS | 2 | Strong Buy | $50.00 | +52.30% | Maintains | 3 months ago |
X4 Pharmaceuticals IncXFOR | 1 | Strong Buy | $10.00 | +194.12% | Maintains | 3 months ago |
Cytokinetics IncCYTK | 2 | Strong Buy | $96.00 | +56.28% | Maintains | 6 months ago |
Soleno Therapeutics IncSLNO | 2 | Strong Buy | $108.00 | +176.50% | Maintains | a year ago |
Edgewise Therapeutics IncEWTX | 1 | Hold | $30.00 | N/A | Initiates Coverage On | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.